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Objectives: To assess whether clinical and patient-reported outcomes are poorer for people 
with inflammatory and non-inflammatory rheumatic diseases living in rural locations. 
Methods: We searched six databases for articles which were primary peer-reviewed research, 
published in English 1990-2019, which focussed on selected rheumatic diseases (rheumatoid 
arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA) or osteoarthritis (OA)), 
and quantified either patient-reported or clinically measured outcomes by a measure of 
rurality or remoteness. Selected articles were synthesised narratively. 
Results: Eight eligible publications, including 753 rural and 929 urban patients, evaluated 
outcomes in RA (5 studies) and OA (3 studies). Studies were small, single centre, and rarely 
provided a definition of rurality. Aspects relating to rurality, such as access to services, were 
not measured. In RA some studies suggested greater functional disability and disease activity 
in rural dwellers. In OA, there was some evidence to suggest that rural dwellers presented 
with more advanced degenerative hip changes, and that illness perceptions and coping 
differed between rural and urban dwellers. No studies examined work outcomes. Potentially 
important confounding factors such as socio-economic status were rarely considered.  
Conclusion: There remains considerable uncertainty whether outcomes differ for rheumatic 
disease patients in rural settings. There is a need for larger-scale studies characterising 
participants in relation to place of residence, in order to determine whether rurality is an 




Significance and Innovation 
• Few and poor quality studies have examined treatment outcomes in patients with 
rheumatic disease living in rural settings.  
• Rurality (and related factors) are poorly defined in studies which have been 
conducted. 
• The role of potentially important confounding factors e.g. social and economic factors 
has not been considered. 
• Mixed-methods approaches are necessary to understand the complex interplay 




Equitable and timely access to specialist, multi-disciplinary care and support for those with 
rheumatic disease is essential to prevent poor outcomes such as joint deformities, functional 
limitations and disability (1). Most specialist services are located in urban areas, yet the 
ageing, multi-morbid population is increasing faster in rural areas (2). Geographical location 
has a significant impact on health inequalities, with social exclusion and isolation, access to 
and awareness of health services, poor housing, low income, travel distance, availability and 
accessibility of transport impacting disproportionately on rural communities (2).  
 
Delivering and sustaining quality healthcare services to rural areas to manage the needs of 
patients with chronic, complex conditions is challenging; for example, recruiting and retaining 
an appropriately skilled workforce, and difficulties realising economies of scale while 
adequately serving sparsely populated areas (2). Many studies have highlighted inadequate 
access to specialist healthcare services for those with rheumatic and musculoskeletal disease 
(RMD) living in rural and remote locations (3). However, whether patients with RMD living in 
rural settings have poorer outcomes remains unknown and there has been, as far as we are 
aware, no review of the evidence.  
 
This systematic review aims to assess whether clinical and patient-reported outcomes are 
poorer for people with inflammatory and non-inflammatory rheumatic diseases living in rural 
locations. 
 
Materials and Methods 
Literature search 
MEDLINE, EMBASE, CINAHL, PsycINFO, Web of Science and Cochrane Library were searched 
using Medical Subject Headings (MeSH) and keywords spanning the following fields: selected 
rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, axial 
spondyloarthritis/ankylosing spondylitis and osteoarthritis), rural or urban area of residence 
and disease outcomes. The latter included clinical status/disease activity, patient or physician 
global assessment (including quality of life) and measures of function. The search strategy 
was initially developed for MEDLINE and adapted for each database.  
Study eligibility 
Publications were eligible for inclusion if they met the following criteria: the publication (1) 
reported primary research and was in a peer-reviewed journal; (2) focused on adult patients 
with rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis/ankylosing 
spondylitis (axSpA) and/or osteoarthritis (OA), or these patient groups could be separately 
identified (3) compared and quantified at least one measure of disease outcome (clinical or 
patient reported) in patients resident in rural and urban areas and (5) was published in English 
between January 1990 and July 2019. We chose 1990 as the earliest date since studies 
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conducted prior to this would have involved considerably different approaches to the clinical 
management of eligible patients.  
Study selection 
After duplicate removal, one reviewer screened all records by title, abstract and subsequently 
full-text to determine inclusion. Uncertainties were resolved by consensus. Bibliographies of 
all included publications were manually searched to obtain additional relevant publications. 
Relevant data were extracted by one reviewer and checked by a second reviewer.  
Due to the heterogeneity of study design, diseases investigated and outcomes measured, a 
meta-analysis was not conducted. Data were extracted and summarised narratively.  
 
Results 
A total of 8 publications were identified as including an eligible study. No additional 
publications were included after screening their reference lists (Figure 1). Eligible studies 
included a total of 753 and 929 patients in rural and urban locations respectively from 8 
countries (2 from Europe, 3 Asia, 2 Africa and 1 from the Americas). Of the eligible studies, 5 
investigated RA, 3 studies OA (1 hip OA, 2 knee OA); there were no studies identified on PsA 
or axSpA. With the exception of one study which was longitudinal in design, all others were 
cross-sectional. Most studies examined patients attending specialist rheumatology or 
orthopaedic services (Table 1). 
In describing studies, focus has principally been on recognised measures of clinical status (e.g. 
disease activity or degree of degeneration), patient/clinician global assessment of disease 
(including quality of life), measures of function and work productivity. Specifically we also 
note the definition used (if any) of rural areas and whether comparisons between populations 
are adjusted for factors which could potentially confound the relationship, namely 
demographic and socioeconomic factors.  
Rheumatoid Arthritis 
Puchner et al (2014) (4) enrolled rheumatologists, primarily, whose practice involved rural 
patients across three provinces of Austria. They provided a questionnaire which was 
distributed to consecutive patients with RA which were then completed at home. In terms of 
rurality this was measured by three parameters a) size of settlement in which they lived b) 
time to travel to provincial capital and c) time to travel to their rheumatologist. Of 124 
participants, 103 described that they lived in a settlement of less than 50,000 persons. There 
were no differences in patient reported health status according to any of the above measures 
of rurality. 
Lekpa et al (2012) (5) recruited patients with RA (according to American College of 
Rheumatology (ACR) 1987 criteria) from the rheumatology outpatient department in Dakar, 
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Senegal. The primary purpose of the report was to compare urban and rural patients. Urban 
patients were defined as those resident in the capital city or in an administrative centre 
(“chef-lieu”) of the region, while all other patients were classified as living in rural settings. 
The study included 180 patients of which 143 (79%) lived in urban areas. Comparing the two 
groups, there were no differences in the presence or type of hand deformities. In those from 
rural areas, the median level of swollen joints (6 v 4) and DAS-28 (7.2 v 6.4) was higher 
although neither difference was statistically significant. A greater proportion of rural patients 
had extra-articular manifestations (70.3% vs 49%). There was no difference in the presence 
of rheumatoid factor nor anti-citrullinated protein antibody (ACPA) between the two groups. 
There was no account of confounding factors made in comparing the groups, but it was noted 
that there were marked gender differences, with men more likely to be from rural areas than 
women (41% v. 18%).  
Zhao et al (2015) (6) recruited 607 patients meeting 1987 ACR criteria for RA from a 
rheumatology outpatient department in Chengdu, China. Residence was categorised as urban 
(n=222), suburban (n=116) or rural (n=269), although no details were provided about how 
this classification was made. Clinical and self-reported information was collected and related 
to the Health Assessment Questionnaire Disability Index (HAQ-DI). Functional disability 
significantly increased across people living in urban, suburban and rural settings. However, 
this study additionally performed a multivariable analysis in which living in a rural setting was 
an independent predictor of increased functional disability (equivalent to a 1.23 point 
increase in HAQ-DI). Other independent predictors were lack of available social support, older 
age, pain, number of times hospitalised and disease duration [note this interpretation is from 
the tables as the text in this study gives contradictory interpretation of the data]. Across the 
study population, 70% were educated below junior high school and 40% had a monthly 
household income monthly per capita < $160. However, education level and household 
income was not adjusted for in the analysis. 
Alarcón et al (2015) (7) recruited 189 patients from the rheumatology clinic of a referral 
centre in one region of Chile. It also acted as a referral centre for other regions. Rural 
residence was defined as “living in the scattered agricultural communities” and 61 
participants were classified as such. Disability was measured using the Spanish version of the 
HAQ and dichotomised into moderate/severe v. slight, due to sparse data. Rural residence 
was associated with moderate/severe disability (Odds Ratio (ORcrude) 3.3, 95% CI (1.2, 11.6)) 
but with considerable uncertainty around the level of association. On multivariable analysis 
the strength of association reduced and was not significant, ORadj 2.1, 95% CI (0.6, 7.1) after 
adjusting for socio-economic status, ethnicity, gender and age. This study was probably too 
small to be able to conduct a robust multivariable analysis.  
In a study which involved comparing black Zimbabwean patients and Caucasian UK patients 
with RA (according to the American Rheumatism Association 1958 criteria), Chikanza et al, 
1994 (8) presented data comparing urban (n=41) and rural (n=43) Zimbabwean participants 
attending a tertiary rheumatology clinic. No definition of how rural status was defined was 
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included in the report. Across a variety of clinical, serological and radiological measures of RA 




Roopsawang and Aree-Ue (2015) (9) undertook an interview survey in three communities in 
Bangkok (Thailand) and three communities in its vicinity. Participants were recruited through 
health centres and community leaders and were considered to have knee osteoarthritis based 
on symptoms and signs using ACR criteria. There were 116 and 112 participants classified as 
rural and urban respectively but there were no details given on the classification. There were 
no confounding factors considered in comparisons but it was noted that those in rural areas 
were considerably more likely to be of normal weight (35% v. 19%) and less likely to have co-
morbidities (35% v. 47%). Only 5.2% of rural dwellers were educated to high school level 
compared to 34.8% of urban dwellers. This study only reported on illness representation and 
coping behaviour. Rural dwellers were less likely to perceive their symptoms as curable, more 
likely to use spiritual coping methods and less likely to use cognitive-focused coping 
behaviours e.g. information seeking and self-care. Those in rural areas reported a lower level 
of emotional impact of symptoms.  
Rapała et al (2015) (10) reported on 200 patients who were about to undergo total hip 
arthroplasty for osteoarthritis. There were 79 and 121 patients classified as rural and urban 
respectively but there was no indication of how the classification was made. In terms of 
clinical status, using a scale proposed by Garlicki and Kreczka patients from rural settings were 
much more likely to have the most advanced level of hip degenerative changes on the three 
point scale “almost 70% of …rural patients …compared to only 44.5% of urban patients”. No 
account was taken of potential confounding factors but data presented demonstrated no 
large differences in mean age, proportion male and mean Body Mass Index (BMI) between 
those classified as urban and rural. 
Çankaya et al (2016) (11) followed 70 patients prospectively with unilateral primary knee 
osteoarthritis who were undergoing arthroplasty. Of these, 45 were classified as rural but no 
information was given on the classification. Outcome was measured six months post-surgery 
by functional status using the Knee Injury and Osteoarthritis Outcome Score Physical Function 
Short Form (KOOS-PS). Quality of life was assessed using the Short-Form 36. There was no 
important or statistically significant difference in change in function or quality of life 
comparing those resident in rural and urban settings. No effect of potential confounding was 
considered (all analyses considered only individual variables) but the study did demonstrate 
that benefit (in terms of quality of life) did increase with higher levels of education and 





We have identified only a small number of studies examining clinical or patient reported 
measures of outcome in rheumatoid arthritis and osteoarthritis, and none in psoriatic arthritis 
and axial spondyloarthritis. All studies are relatively small, rarely provide a definition of rural 
status (and specifically do not measure aspects related to rurality such as access to services), 
and do not consider factors which could confound any differences observed between urban 
and rural patients. No eligible studies examined work outcomes between urban and rural 
patients.  
 
The aim of this systematic review was to determine whether clinical and patient-reported 
outcomes were poorer for people with inflammatory and non-inflammatory rheumatic 
diseases living in rural locations. We excluded papers that did not differentiate between 
specific rheumatic diseases. Inflammatory and non-inflammatory rheumatic disease have 
different underlying pathophysiology, service delivery and resource requirements. To help 
inform the type of approaches required to reduce any inequalities, comparisons therefore 
need to be precise; any observed differences in outcomes are only meaningful if differences 
between and across conditions can be determined. For example, are differences in outcome 
driven by specific conditions, or common across all conditions? However, we did identify two 
large studies from the US (12) and Australia (13) which, although did not differentiate 
between types of arthritis, were otherwise relevant. Kovac et al (12) examined health-related 
quality of life among 1,191 individuals with self-reported arthritis (mainly RA and OA). After 
adjusting for socio-economic status, rural residency was an independent predictor of poorer 
physical and mental health. Dowsey et al (13) found that rural patients in Australia presented 
at a younger age for hip and knee replacement, and with less severe radiographic disease. 
The authors postulate this may reflect rural dwellers working in physical jobs seeking referral 
earlier due to concerns about disease progression, and lack of multi-disciplinary support for 
self-management in rural communities. In contrast, Rapala et al, 2005 (10) found that rural 
patients in Poland presented with more severe degenerative joint disease. This suggests 
potential differences in illness perceptions, health seeking behaviour and coping mechanisms 
between urban and rural dwellers with arthritis across different healthcare contexts and 
cultures.  
Our systematic literature review has several limitations. Data was scare and most studies only 
sampled rural patients attending urban-based specialist centres; this is likely to 
underestimate any geographical differences. The term “rurality” can encompass many 
relevant issues in terms of health and health care including; population density, population 
size (which are related to rurality), and availability of and travel time to healthcare services 
(more related to remoteness). Only one included study attempted to measure more than one 
of these aspects – most relied on a single geographical descriptor or did not provide any 
definition of rurality. Studies were conducted across diverse healthcare contexts, with 
significant variation in access and provision of specialist RMD services, and payment systems. 
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However, these important contextual factors and their potential influence on access to 
services for those living in rural areas were not measured, making it difficult to draw 
comparisons and explore reasons for any disparities between urban and rural dwellers. Most 
studies were cross-sectional which precluded examination of changes over time or response 
to therapy.  
Low socioeconomic status has been associated with worse clinical outcomes, decreased 
functional ability and reduced quality of life in RA (14). Whilst rural areas in developed 
countries are often considered to be less deprived, ‘hidden’ rural deprivation is increasingly 
recognised, representing a complex interplay between factors associated with income, 
social circumstances, access to services, and patient choice that is not captured by existing 
area-based measurements of deprivation (15).  Whilst several studies in this review 
reported lower education and income levels in rural settings, most eligible studies did not 
adjust for socio-economic status. Those that did (7) were underpowered to examine 
multivariable relationships. It is therefore difficult to determine, based on existing evidence, 
whether rurality is an independent predictor of poor outcome in RMD or a surrogate marker 
for socio-economic status. We did not undertake a formal quality assessment as we had 
already identified that almost all studies failed in terms of two key issues: the definition of 
rural settings and taking account of confounding factors when examining the relationship 
between residence and outcome. 
 
In conclusion, we have identified key priorities for future research. Studies using population 
level data are necessary to capture the burden of disease and health outcomes in RMD 
between rural and urban areas. Differentiating between conditions is an important point to 
be considered when designing future research to examine rural-urban differences in 
outcomes in rheumatic disease. There is also a need to define rurality consistently to allow 
comparison across studies, and have valid and measurable indicators of rural deprivation to 
explore the independent effect of rurality on health outcomes. Mixed-methods approaches 
provide additional opportunities to explore the complex interplay between rurality and health 
outcomes in RMD. 
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* Exclusion of full-text articles due to the following reasons: Full-text not English (n = 1), 
conference abstract only (n=9), no primary peer-reviewed study (n=10), not investigating 
disease of interest/did not differentiate between different types of arthritis (n=29), no 
comparison of rural and urban patients (n =44), not investigating disease outcomes (n=34).  
Records identified through database 
searching (n = 4,994):  
MEDLINE (904), EMBASE (1,568), 
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